Production of α2,6-sialylated IgG1 in CHO cells

References

• Chan AC, Carter PJ. Therapeutic antibodies for autoimmunity and inflammation. Nat Rev Immunol 2010; 10:301-16; PMID:20414204; http://dx.doi.org/10.1038/nri2761
   PubMed Web of Science ®Google Scholar
• Albanesi M, Daëron M. The interactions of therapeutic antibodies with Fc receptors. Immunol Lett 2012; 143:20-7; PMID:22553779; http://dx.doi.org/10.1016/j.imlet.2012.02.005
   PubMed Web of Science ®Google Scholar
• Scott AM, Allison JP, Wolchok JD. Monoclonal antibodies in cancer therapy. Cancer Immun 2012; 12:14; PMID:22896759
   PubMedGoogle Scholar
• Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol 2007; 25:21-50; PMID:17029568; http://dx.doi.org/10.1146/annurev.immunol.25.022106.141702
   PubMed Web of Science ®Google Scholar
• Patel D, Guo X, Ng S, Melchior M, Balderes P, Burtrum D, Persaud K, Luna X, Ludwig DL, Kang X. IgG isotype, glycosylation, and EGFR expression determine the induction of antibody-dependent cellular cytotoxicity in vitro by cetuximab. CA Hum Antibodies 2010; 19:89-99.
   PubMedGoogle Scholar
• Houde D, Peng Y, Berkowitz SA, Engen JR. Post-translational modifications differentially affect IgG1 conformation and receptor binding. Mol Cell Proteomics 2010; 9:1716-28; http://dx.doi.org/10.1074/mcp.M900540-MCP200
   PubMed Web of Science ®Google Scholar
• Leatherbarrow RJ, Rademacher TW, Dwek RA, Woof JM, Clark A, Burton DR, Richardson N, Feinstein A. Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor. Mol Immunol 1985; 22:407-15; PMID:4033665; http://dx.doi.org/10.1016/0161-5890(85)90125-7
   PubMed Web of Science ®Google Scholar
• Tao MH, Morrison SL. Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J Immunol 1989; 143:2595-601; PMID:2507634
   PubMed Web of Science ®Google Scholar
• Wormald MR, Rudd PM, Harvey DJ, Chang S-C, Scragg IG, Dwek RA. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Biochemistry 1997; 36:1370-80; PMID:9063885; http://dx.doi.org/10.1021/bi9621472
   PubMed Web of Science ®Google Scholar
• Krapp S, Mimura Y, Jefferis R, Huber R, Sondermann P. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J Mol Biol 2003; 325:979-89; PMID:12527303; http://dx.doi.org/10.1016/S0022-2836(02)01250-0
   PubMed Web of Science ®Google Scholar
• Voynov V, Chennamsetty N, Kayser V, Helk B, Forrer K, Zhang H, Fritsch C, Heine H, Trout BL. Dynamic fluctuations of protein-carbohydrate interactions promote protein aggregation. PloS One 2009; 4:e8425; PMID:20037630; http://dx.doi.org/10.1371/journal.pone.0008425
   PubMedGoogle Scholar
• Holland M, Yagi H, Takahashi N, Kato K, Savage COS, Goodall DM, Jefferis R. Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis. Biochim Biophys Acta 2006; 1760:669-77; PMID:16413679; http://dx.doi.org/10.1016/j.bbagen.2005.11.021
   PubMed Web of Science ®Google Scholar
• Wuhrer M, Stam JC, van de Geijn FE, Koeleman CA, Verrips CT, Dolhain RJEM, Hokke CH, Deelder AM. Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum. Proteomics 2007; 7:4070-81; PMID:17994628; http://dx.doi.org/10.1002/pmic.200700289
   PubMed Web of Science ®Google Scholar
• Anumula KR. Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc. J Immunol Methods 2012; 382:167-76; PMID:22683540; http://dx.doi.org/10.1016/j.jim.2012.05.022
   PubMed Web of Science ®Google Scholar
• Ferrara C, Bru P, Suter T, Moser S, Pu U, Uman P. Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous b1, 4-N-acetylglucosaminyltransferase III and Golgi a-mannosidase II. Biotechnol Appl Biochem 2006; 93:851-61.
   Google Scholar
• Mizushima T, Yagi H, Takemoto E, Shibata-Koyama M, Isoda Y, Iida S, Masuda K, Satoh M, Kato K. Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans. Genes Cells 2011; 16:1071-80; PMID:22023369; http://dx.doi.org/10.1111/j.1365-2443.2011.01552.x
   PubMed Web of Science ®Google Scholar
• Shields RL, Lai J, Keck R, O'Connell LY, Hong K, Meng YG, Weikert SH, Presta LG. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem 2002; 277:26733-40; PMID:11986321; http://dx.doi.org/10.1074/jbc.M202069200
   PubMed Web of Science ®Google Scholar
• Shinkawa T, Nakamura K, Yamane N, Shoji-Hosaka E, Kanda Y, Sakurada M, Uchida K, Anazawa H, Satoh M, Yamasaki M, et al. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem 2003; 278:3466-73; PMID:12427744; http://dx.doi.org/10.1074/jbc.M210665200
   PubMed Web of Science ®Google Scholar
• Hodoniczky J, Zheng YZ, James DC. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro. Biotechnol Prog 2005; 21:1644-52; PMID:16321047; http://dx.doi.org/10.1021/bp050228w
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Anthony RM, Ravetch JV. Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. Proc Natl Acad Sci USA 2007; 104:8433-7; PMID:17485663; http://dx.doi.org/10.1073/pnas.0702936104
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 2006; 313:670-3; PMID:16888140; http://dx.doi.org/10.1126/science.1129594
   PubMed Web of Science ®Google Scholar
• Scallon BJ, Tam SH, McCarthy SG, Cai AN, Raju TS. Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. Mol Immunol 2007; 44:1524-34; PMID:17045339; http://dx.doi.org/10.1016/j.molimm.2006.09.005
   PubMed Web of Science ®Google Scholar
• Anthony RM, Wermeling F, Karlsson MCI, Ravetch JV. Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc Natl Acad Sci USA 2008; 105:19571-8; PMID:19036920; http://dx.doi.org/10.1073/pnas.0810163105
   PubMed Web of Science ®Google Scholar
• Guhr T, Bloem J, Derksen NIL, Wuhrer M, Koenderman AHL, Aalberse RC, Rispens T. Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia. PloS One 2011; 6:e21246; PMID:21731683; http://dx.doi.org/10.1371/journal.pone.0021246
   PubMed Web of Science ®Google Scholar
• Leontyev D, Katsman Y, Ma X-Z, Miescher S, Käsermann F, Branch DR. Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin. Transfusion 2012; 52:1799–1805; PMID:22257295; http://dx.doi.org/10.1111/j.1537-2995.2011.03517
   PubMed Web of Science ®Google Scholar
• Käsermann F, Boerema DJ, Rüegsegger M, Hofmann A, Wymann S, Zuercher AW, Miescher S. Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionation. PloS one 2012; 7:e37243; http://dx.doi.org/10.1371/journal.pone.0037243
   PubMed Web of Science ®Google Scholar
• Yu X, Vasiljevic S, Mitchell DA, Crispin M, Scanlan CN. Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain. J Mol Biol 2013; 425:1253-8; PMID:23416198; http://dx.doi.org/10.1016/j.jmb.2013.02.006
   PubMed Web of Science ®Google Scholar
• Yu X, Baruah K, Harvey DJ, Vasiljevic S, Alonzi DS, Song B-D, Higgins MK, Bowden Ta, Scanlan CN, Crispin M. Engineering hydrophobic protein-carbohydrate interactions to fine-tune monoclonal antibodies. J Am Chem Soc 2013; 135:9723-32; PMID:23745692; http://dx.doi.org/10.1021/ja4014375
   PubMed Web of Science ®Google Scholar
• Campbell IK, Miescher S, Branch DR, Mott PJ, Lazarus AH, Han D, Maraskovsky E, Zuercher AW, Neschadim A, Leontyev D, et al. Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils. J Immunol 2014; 192:5031-8; PMID:24760152; http://dx.doi.org/10.4049/jimmunol.1301611
   PubMed Web of Science ®Google Scholar
• Massoud AH, Yona M, Xue D, Chouiali F, Alturaihi H, Ablona A, Mourad W, Piccirillo CA, Mazer BD. Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells. J Allergy Clin Immunol 2014; 133:853-63 e5; PMID:24210883; http://dx.doi.org/10.1016/j.jaci.2013.09.029
   PubMed Web of Science ®Google Scholar
• Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi MA, Samyn-Petit B, Julien S, Delannoy P. The human sialyltransferase family. Biochimie 2001; 83:727-37; PMID:11530204; http://dx.doi.org/10.1016/S0300-9084(01)01301-3
   PubMed Web of Science ®Google Scholar
• Dalziel M, McFarlane I, Axford JS. Lectin analysis of human immunoglobulin G N-glycan sialylation. Glycoconj J 1999; 16:801-7; PMID:11133020; http://dx.doi.org/10.1023/A:1007183915921
   PubMed Web of Science ®Google Scholar
• Jassal R, Jenkins N, Charlwood J, Camilleri P, Jefferis R, Lund J. Sialylation of human IgG-Fc carbohydrate by transfected rat alpha2,6-sialyltransferase. Biochem Biophys Res Commun 2001; 286:243-9; PMID:11500028; http://dx.doi.org/10.1006/bbrc.2001.5382
   PubMed Web of Science ®Google Scholar
• Zhao J, Simeone DM, Heidt D, Anderson MA, Lubman DM. Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum. J Proteome Res 2006; 5:1792-802; PMID:16823988; http://dx.doi.org/10.1021/pr060034r
   PubMed Web of Science ®Google Scholar
• Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, James C, Ravetch JV. A recombinant IgG Fc that recapitulates the anti-inflammatory activity of IVIG. Science 2008; 320:373-6; PMID:18420934; http://dx.doi.org/10.1126/science.1154315
   PubMed Web of Science ®Google Scholar
• Oaks M, Taylor S, Shaffer J. Autoantibodies targeting tumor-associated antigens in metastatic cancer: sialylated IgGs as candidate anti-inflammatory antibodies. Oncoimmunology 2013; 2:e24841; PMID:23894724
   PubMedGoogle Scholar
• Stadlmann J, Pabst M, Altmann F. Analytical and functional aspects of antibody sialylation. J Clin Immunol 2010; 30:S15-S9; http://dx.doi.org/10.1007/s10875-010-9409-2
   PubMed Web of Science ®Google Scholar
• Raju TS, Briggs JB, Chamow SM, Winkler ME, Jones AJ. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues. Biochemistry 2001; 40:8868-76; PMID:11467948; http://dx.doi.org/10.1021/bi010475i
   PubMed Web of Science ®Google Scholar
• Barb AW, Brady EK, Prestegard JH. Branch-specific sialylation of IgG-Fc glycans by ST6Gal-I. Biochemistry 2009; 48:9705-7; PMID:19772356; http://dx.doi.org/10.1021/bi901430h
   PubMed Web of Science ®Google Scholar
• Lund J, Takahashi N, Pound JD, Goodall M, Jefferis R. Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains. J Immunol 1996; 157:4963-9; PMID:8943402
   PubMed Web of Science ®Google Scholar
• Kaneko E, Niwa R. Optimizing therapeutic antibody function: progress with Fc domain engineering. BioDrugs 2011; 25:1-11; PMID:21033767; http://dx.doi.org/10.2165/11537830-000000000-00000
   PubMed Web of Science ®Google Scholar
• Rose RJ, van Berkel PHC, van den Bremer ETJ, Labrijn AF, Vink T, Schuurman J, Heck AJR, Parren PWHI. Mutation of Y407 in the CH3 domain dramatically alters glycosylation and structure of human IgG. mAbs 2013; 5:219-28; PMID:23406897; http://dx.doi.org/10.4161/mabs.23532
   PubMed Web of Science ®Google Scholar
• Lefranc M-P, Giudicelli V, Ginestoux C, Jabado-Michaloud J, Folch G, Bellahcene F, Wu Y, Gemrot E, Brochet X, Lane J, et al.. IMGT®, the international ImMunoGeneTics information system®. Nucleic Acids Res 2009; 37:D1006–D12; PMID:18978023; http://dx.doi.org/10.1093/nar/gkn838
   PubMed Web of Science ®Google Scholar
• Lee EU, Roth J, Paulson JC. Alteration of terminal glycosylation sequences on N-linked oligosaccharides of Chinese hamster ovary cells by expression of beta-galactoside alpha 2,6-sialyltransferase. J Biol Chem 1989; 264:13848-55; PMID:2668274
   PubMed Web of Science ®Google Scholar
• Weikert S, Papac D, Briggs J, Cowfer D, Tom S, Gawlitzek M, Lofgren J, Mehta S, Chisholm V, Modi N, et al. Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins. Nat Biotechnol 1999; 17:1116-21; PMID:10545921; http://dx.doi.org/10.1038/15104
   PubMed Web of Science ®Google Scholar
• Onitsuka M, Kim W-D, Ozaki H, Kawaguchi A, Honda K, Kajiura H, Fujiyama K, Asano R, Kumagai I, Ohtake H, et al. Enhancement of sialylation on humanized IgG-like bispecific antibody by overexpression of α2,6-sialyltransferase derived from Chinese hamster ovary cells. Appl Microbiol Biotechnol 2012; 94:69-80; PMID:22205442; http://dx.doi.org/10.1007/s00253-011-3814-1
   PubMed Web of Science ®Google Scholar
• Raymond C, Robotham A, Kelly J, Lattova E, Perreault H, Durocher Y. Production of highly sialylated monoclonal antibodies. In: Petrescu S, ed. Rijeka, Croatia: Intech; 2012.
   Google Scholar
• Kumar N, Gammell P, Clynes M. Proliferation control strategies to improve productivity and survival during CHO based production culture: a summary of recent methods employed and the effects of proliferation control in product secreting CHO cell lines. Cytotechnology 2007; 53:33-46; PMID:19003188; http://dx.doi.org/10.1007/s10616-007-9047-6
   PubMed Web of Science ®Google Scholar
• Clark KJ-R, Griffiths J, Bailey KM, Harcum SW. Gene-expression profiles for five key glycosylation genes for galactose-fed CHO cells expressing recombinant IL-4/13 cytokine trap. Biotechnol Bioeng 2005; 90:568-77; PMID:15818560; http://dx.doi.org/10.1002/bit.20439
   PubMed Web of Science ®Google Scholar
• Barb AW, Prestegard JH. NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic. Nat Chem Biol 2011; 7:147-53; PMID:21258329; http://dx.doi.org/10.1038/nchembio.511
   PubMed Web of Science ®Google Scholar
• Barb AW, Meng L, Gao Z, Johnson RW, Moremen KW, Prestegard JH. NMR characterization of immunoglobulin G Fc glycan motion on enzymatic sialylation. Biochemistry 2012; 51:4618-26; PMID:22574931; http://dx.doi.org/10.1021/bi300319q
   PubMed Web of Science ®Google Scholar
• Ramasamy V, Ramakrishnan B, Boeggeman E, Ratner DM, Seeberger PH, Qasba PK. Oligosaccharide preferences of beta1,4-galactosyltransferase-I: crystal structures of Met340His mutant of human beta1,4-galactosyltransferase-I with a pentasaccharide and trisaccharides of the N-glycan moiety. CA J Mol Biol 2005; 353:53-67.
   PubMed Web of Science ®Google Scholar
• Weinstein J, de Souza-e-Silva U, Paulson JC. Sialylation of glycoprotein oligosaccharides N-linked to asparagine. J Biol Chem 1982; 257:13845-53; PMID:7142180
   PubMed Web of Science ®Google Scholar
• Hossler P, Goh LT, Lee MM, Hu WS. GlycoVis: visualizing glycan distribution in the protein N-glycosylation pathway in mammalian cells. Biotechnol Bioeng 2006; 95:946-60; PMID:16807922; http://dx.doi.org/10.1002/bit.21062
   PubMed Web of Science ®Google Scholar
• Blanken WM, van Vliet A, van den Eijnden DH. Branch specificity of bovine colostrum and calf thymus UDP-Gal: N-acetylglucosaminide beta-1,4-galactosyltransferase. J Biol Chem 1984; 259:15131-5; PMID:6439717
   PubMed Web of Science ®Google Scholar
• Paquet MR, Narasimhan S, Schachter H, Moscarello MA. Branch specificity of purified rat liver Golgi UDP-galactose: N-acetylglucosamine beta-1,4-galactosyltransferase. Preferential transfer of galactose on the GlcNAc beta-1,2-Man alpha-1,3-branch of a complex biantennary Asn-linked oligosaccharide. J Biol Chem 1984; 259:4716-21; PMID:6425277
   PubMed Web of Science ®Google Scholar
• Ramakrishnan B, Balaji PV, Qasba PK. Crystal structure of beta1,4-galactosyltransferase complex with UDP-Gal reveals an oligosaccharide acceptor binding site. J Mol Biol 2002; 318:491-502; PMID:12051854; http://dx.doi.org/10.1016/S0022-2836(02)00020-7
   PubMed Web of Science ®Google Scholar
• Hassinen A, Pujol FM, Kokkonen N, Pieters C, Kihlström M, Korhonen K, Kellokumpu S. Functional organization of Golgi N- and O-glycosylation pathways involves pH-dependent complex formation that is impaired in cancer cells. J Biol Chem 2011; 286:38329-40; PMID:21911486; http://dx.doi.org/10.1074/jbc.M111.277681
   PubMed Web of Science ®Google Scholar
• Redpath S, Michaelsen TE, Sandlie I, Clark MR. The influence of the hinge region length in binding of human IgG to human Fcgamma receptors. Hum Immunol 1998; 59:720-7; PMID:9796740; http://dx.doi.org/10.1016/S0198-8859(98)00075-5
   PubMed Web of Science ®Google Scholar
• Shi C, Shin YO, Hanson J, Cass B, Loewen MC, Durocher Y. Purification and characterization of a recombinant G-protein-coupled receptor, Saccharomyces cerevisiae Ste2p, transiently expressed in HEK293 EBNA1 cells. Biochemistry 2005; 44:15705-14; PMID:16313173; http://dx.doi.org/10.1021/bi051292p
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu X, Bell A, To R, Nath T, Azizi A, Li J, Cass B, Durocher Y. Transient expression and purification of chimeric heavy chain antibodies. Protein Expression Purif 2009; 65:77-82; http://dx.doi.org/10.1016/j.pep.2008.10.011
   PubMed Web of Science ®Google Scholar
• Durocher Y, Perret S, Kamen A. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res 2002; 30:E9; PMID:11788735; http://dx.doi.org/10.1093/nar/30.2.e9
   PubMed Web of Science ®Google Scholar
• Use of PEI for transfection may be covered by existing intellectual property rights iUP, 013,240, European Patent 0,770,140, and foreign equivalents for which further information may be obtained by contacting [email protected]
   Google Scholar
• Bigge JC, Patel TP, Bruce JA, Goulding PN, Charles SM, Parekh RB. Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. Anal Biochem 1995; 230:229-38; PMID:7503412; http://dx.doi.org/10.1006/abio.1995.1468
   PubMed Web of Science ®Google Scholar
• Guile GR, Rudd PM, Wing DR, Prime SB, Dwek RA. A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal Biochem 1996; 240:210-26; PMID:8811911; http://dx.doi.org/10.1006/abio.1996.0351
   PubMed Web of Science ®Google Scholar
• Royle L, Radcliffe CM, Dwek RA, Rudd PM. Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions. Methods Mol Biol 2006; 347:125-43; PMID:17072008
   PubMedGoogle Scholar